Creative Medical Technology Holdings Inc (CELZ)

[escalate]

U.S. and international agreements have been reached for exclusive distribution rights for the FDA approved Generation 2 bone marrow harvest technology which has been used with multiple ED patients in the past 90 days with excellent results. By replacing the centrifuge technology with our Generation 2 technology we realize the following benefits;

Reduced bone marrow harvest from 60cc to 20cc.
Higher cell count (less blood harvested).
Reduced procedure time.
Reduced startup cost for physician by eliminating centrifuge.[/b]